Answers are grounded in this paper and cite their sources.
This retrospective cohort study evaluated the association between pretransfusion platelet count and outcomes in adults receiving platelets after sepsis-associated acute kidney injury (SA-AKI), using data from the Medical Information Mart for Intensive Care IV. The exposure was the minimum platelet count during the 48 h before the first eligible transfusion. The primary cohort included 1047 patients with counts ≤ 100 × 10 9 /L. Follow-up began at transfusion. Multivariable Cox regression and restricted cubic splines (RCS) were used to assess associations with 28-day (primary) and 90-day all-cause mortality. Each 10 × 10 9 /L increase in platelet count was associated with lower 28-day mortality (adjusted hazard ratio [HR] 0.915; 95% confidence interval [CI] 0.864–0.970) and 90-day mortality (HR 0.915; 95% CI 0.868–0.964). RCS analysis in the primary cohort showed no clear evidence of nonlinearity. No statistically significant association was detected with post-transfusion intensive care unit length of stay. Among adults receiving platelets after SA-AKI onset with pretransfusion platelet counts ≤ 100 × 10 9 /L, higher counts were associated with lower 28- and 90-day mortality. These findings support further evaluation of pretransfusion platelet count as a prognostic marker in this population.
No takes yet. Share an insight, caveat, or question.
Ye et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: